Hjem › Diffus sclerodermi › Tennessee
Diffus sclerodermi kliniske forsøg i Tennessee
4 studier for Diffus sclerodermi søger deltagere på steder i Tennessee.
Officiel studietekst (engelsk)
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
- West Tennessee Research Institute, Jackson
RekruttererFase 2
Alder 18 til 70 · Alle køn · Opdateret 28. sep. 2026 · NCT06470048Platform Clinical Study for Conquering Scleroderma
- Vanderbilt University Medical Center, Nashville
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 18. aug. 2026 · NCT06195072AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Artiva Investigational Site Hixson, Hixson
- Artiva Investigational Site Jackson, Jackson
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 31. jul. 2026 · NCT06991114The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life
- Vanderbilt University Medical Center, Nashville
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 8. jan. 2026 · NCT06675344Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.